Literature DB >> 27489053

Secondary preventive medication use in a prevalent population-based cohort of acute coronary syndrome survivors.

Anthony S Gunnell1, Joseph Hung1,2, Matthew W Knuiman1, Lee Nedkoff1, Malcolm Gillies3, Elizabeth Geelhoed1, Michael S T Hobbs1, Judith M Katzenellenbogen4, Jamie M Rankin5, Michael Ortiz6, Tom G Briffa1, Frank M Sanfilippo1.   

Abstract

AIM: Describe the dispensing patterns for guideline-recommended medications during 2008 in people with acute coronary syndrome (ACS) and how dispensing varies by gender and time since last ACS hospitalization.
METHOD: A descriptive cohort spanning 20 years of people alive post-ACS in 2008. We extracted all ACS hospitalizations and deaths in Western Australia (1989-2008), and all person-linked Pharmaceutical Benefits Scheme claims nationally for 2008. Participants were 23 642 men and women (36.8%), alive and aged 65-89 years in mid-2008 who were hospitalized for ACS between 1989 and 2008. Main outcome was the proportion of the study cohort (in 2008) dispensed guideline-recommended cardiovascular medications in that year. Adjusted odds ratios estimating the association between type (and number) of guideline-recommended medications and time since last ACS hospitalization.
RESULTS: Medications most commonly dispensed in 2008 were statins (79.6% of study cohort) and then angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers (ACEi/ARBs) (71.1%), aspirin or clopidogrel (59.4%), and β-blockers (54.6%). Only 51.8% of the cohort was dispensed three or more of these drug types in 2008. Women with ACS were 18% less likely to be dispensed statins (adjusted odds ratio (OR)=0.82; 95% CI 0.76-0.88). Overall, for each incremental year since last ACS admission, there was an 8% increased odds (adjusted OR=1.08; 95% CI 1.07-1.08) of being dispensed fewer of the recommended drug regimen in 2008.
CONCLUSION: Longer time since last ACS admission was associated with dispensing fewer medications types and combinations in 2008. Interventions are warranted to improve dispensing long term and any apparent gender inequality in the drug class filled.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Acute coronary syndrome; Evidence-based practice; Gender; Pharmacoepidemiology; Prevention and control

Mesh:

Substances:

Year:  2016        PMID: 27489053     DOI: 10.1111/1755-5922.12212

Source DB:  PubMed          Journal:  Cardiovasc Ther        ISSN: 1755-5914            Impact factor:   3.023


  2 in total

1.  Gender disparity in the prescription of secondary prevention medications in a Malaysian primary care clinic.

Authors:  Noorhida Baharudin; Ahmad Muslim Ahmad Roslan; Mohamed Syarif Mohamed Yassin; Anis Safura Ramli; Aiza Nur Izdihar Zainal Abidin; Nurul Hidayatullaila Sahar; Nor Shazatul Salwana Din; Izyana Syazlin Ibrahim; Siti Nur Hidayah Abd Rahim; Nur Athirah Rosli
Journal:  Malays Fam Physician       Date:  2021-06-08

2.  The changing face of Australian data reforms: impact on pharmacoepidemiology research.

Authors:  Juliana de Oliveira Costa; Claudia Bruno; Andrea L Schaffer; Smriti Raichand; Emily A Karanges; Sallie-Anne Pearson
Journal:  Int J Popul Data Sci       Date:  2021-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.